Trials / Completed
CompletedNCT02022683
To Improve Lung Function and Symptoms for Emphysema Patients Using Zephyr Valves
A Multi-center, Prospective, Randomized, Controlled Trial of Endobronchial Valve Therapy vs. Standard of Care in Heterogeneous Emphysema
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 97 (actual)
- Sponsor
- Pulmonx Corporation · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
To compare the clinical outcomes of Endoscopic Lung Volume Reduction (ELVR) using Pulmonx Zephyr Valves vs. Standard of Care (SoC) in the treatment of heterogeneous emphysema subjects in a controlled trial design setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ELVR (Endoscopic Lung Volume Reduction) with Zephyr Valves |
Timeline
- Start date
- 2014-01-28
- Primary completion
- 2017-01-20
- Completion
- 2018-09-27
- First posted
- 2013-12-30
- Last updated
- 2019-07-02
Locations
17 sites across 6 countries: Belgium, France, Germany, Netherlands, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT02022683. Inclusion in this directory is not an endorsement.